SBI Life Insuran

  • Market Cap: Large Cap
  • Industry: Insurance
  • ISIN: INE123W01016
  • NSEID: SBILIFE
  • BSEID: 540719
INR
2,025.40
0.6 (0.03%)
BSENSE

Dec 24

BSE+NSE Vol: 3.58 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.58 lacs (-23.99%) Volume

Shareholding (Sep 2025)

FII

21.85%

Held by 791 FIIs

DII

2.25%

Held by 83 DIIs

Promoter

55.36%

What does SBI Life Insuran do?

06-Jun-2025

SBI Life Insurance Company Ltd, established in 2001 as a joint venture between the State Bank of India and BNP Paribas Cardif S.A., is a leading life insurance provider in India with a market cap of Rs 178,198 Cr and reported net sales of 23,861 Cr and net profit of 814 Cr for March 2025. Key metrics include a P/E ratio of 74.00 and a return on equity of 14.21%.

Overview:<BR>SBI Life Insurance Company Ltd is a leading life insurance provider in India, operating within the large-cap insurance industry.<BR><BR>History:<BR>Established in 2001, SBI Life Insurance is a joint venture between the State Bank of India and BNP Paribas Cardif S.A. The latest quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 23,861 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 814 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 178,198 Cr (Large Cap)<BR><BR>Key Metrics:<BR>- P/E: 74.00<BR>- Industry P/E: 23<BR>- Dividend Yield: 0.15%<BR>- Debt-Equity: -0.11<BR>- Return on Equity: 14.21%<BR>- Price to Book: 10.46<BR><BR>Contact Details:<BR>Address: Natraj M V Road Andheri(East), Western Express Highway Juncti Mumbai Maharashtra : 400069<BR>Tel: 91-22-61910000<BR>Email: investor@sbilife.co.in/aniket.karan<BR>Website: http://www.sbilife.co.in

Read More

When is the next results date for SBI Life Insuran?

06-Jun-2025

No Upcoming Board Meetings

Has SBI Life Insuran declared dividend?

06-Jun-2025

Yes, SBI Life Insurance has declared a 27% dividend, amounting to ₹2.7 per share, with an ex-date of March 7, 2025. The company has shown strong total returns across various periods, reflecting its robust financial health.

SBI Life Insurance Company Ltd has declared a 27% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 27%<BR>- Amount per share: 2.7<BR>- Ex-date: 07 Mar 25<BR><BR>Dividend Yield: 0.15%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 22.37%, the dividend return was 0.18%, leading to a total return of 22.55%.<BR><BR>Over the past year, the price return was 22.87%, the dividend return was 0.19%, resulting in a total return of 23.06%.<BR><BR>In the last 2 years, the price return was 44.93%, the dividend return was 0.42%, culminating in a total return of 45.35%.<BR><BR>For the 3-year period, the price return was 55.37%, the dividend return was 0.74%, which brought the total return to 56.11%.<BR><BR>In the 4-year span, the price return was 79.25%, the dividend return was 0.99%, leading to a total return of 80.24%.<BR><BR>Over the last 5 years, the price return was 122.45%, the dividend return was 1.52%, resulting in a total return of 123.97%.<BR><BR>Overall, SBI Life Insurance has declared a substantial dividend alongside strong total returns across various periods, indicating a positive performance for investors. The consistent growth in both price and dividend returns reflects the company's robust financial health.

Read More

Is SBI Life Insuran overvalued or undervalued?

09-Jun-2025

As of April 28, 2025, SBI Life Insurance Co. Ltd. is considered undervalued with a valuation grade shift to very attractive, featuring a PE ratio of 74.03, an EV to EBIT of 131.31, and a year-to-date return of 28.59%, outperforming the Sensex's 5.58%.

As of 28 April 2025, the valuation grade for SBI Life Insurance Co. Ltd. has moved from very expensive to very attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of 74.03, an EV to EBIT of 131.31, and a ROE of 14.21%. <BR><BR>In comparison to its peers, SBI Life's valuation metrics align closely with those of similar companies, such as HDFC Life Insurance, which has a PE ratio of approximately 70.00, and ICICI Prudential Life Insurance, with an EV to EBITDA of around 120.00. Notably, SBI Life has outperformed the Sensex with a year-to-date return of 28.59% compared to the Sensex's 5.58%, reinforcing its attractiveness as an investment opportunity.

Read More

Who are the peers of the SBI Life Insuran?

16-Jul-2025

SBI Life Insurance's peers include HDFC Life, ICICI Lombard, ICICI Prudential Life, Max Financial, and others. It has an average growth rating and a 1-year return of 12.48%, lower than Max Financial's 50.88% but higher than New India Assurance's -35.73%.

Peers: The peers of SBI Life Insuran are Life Insurance, HDFC Life Insur., ICICI Lombard, ICICI Pru Life, General Insuranc, Max Financial, Go Digit General, New India Assura, Star Health Insu, and Niva Bupa Health.<BR><BR>Quality Snapshot: Excellent management risk is observed at ICICI Lombard and Go Digit General, while Average management risk is found at Life Insurance, SBI Life Insuran, HDFC Life Insur., ICICI Pru Life, General Insuranc, Max Financial, Star Health Insu, and Niva Bupa Health, and Below Average management risk is noted at New India Assura. Growth is rated as Excellent for Go Digit General and Niva Bupa Health, Good for HDFC Life Insur., Average for SBI Life Insuran, Life Insurance, General Insuranc, Max Financial, and Star Health Insu, and Below Average for ICICI Pru Life and New India Assura. All peers have an Excellent capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Max Financial at 50.88%, while the peer with the lowest is New India Assura at -35.73%. SBI Life Insuran's 1-year return is 12.48%, which is higher than New India Assura but lower than Max Financial. Additionally, General Insuranc, ICICI Pru Life, New India Assura, and Star Health Insu have negative six-month returns.

Read More

Who are in the management team of SBI Life Insuran?

16-Jul-2025

As of March 2023, the management team of SBI Life Insurance includes Chairman Dinesh Kumar Khara, Managing Director & CEO Mahesh Kumar Sharma, and several independent non-executive directors: Deepak Amin, Narayan Seshadri, Shobinder Duggal, T M Bhasin, and Usha Sangwan.

As of March 2023, the management team of SBI Life Insurance includes the following members:<BR><BR>1. Dinesh Kumar Khara - Chairman (Non-Executive) & Director (Non-Independent)<BR>2. Deepak Amin - Independent Non-Executive Director<BR>3. Narayan Seshadri - Independent Non-Executive Director<BR>4. Shobinder Duggal - Independent Non-Executive Director<BR>5. T M Bhasin - Independent Non-Executive Director<BR>6. Usha Sangwan - Independent Non-Executive Director<BR>7. Mahesh Kumar Sharma - Managing Director & CEO<BR><BR>This team comprises a mix of executive and independent directors, with Mahesh Kumar Sharma serving as the CEO.

Read More

Who are the top shareholders of the SBI Life Insuran?

17-Jul-2025

The top shareholders of SBI Life Insurance are the State Bank of India with 55.38%, followed by foreign institutional investors at 21.88%, and mutual funds holding 15%. ICICI Prudential Mutual Fund is the largest public shareholder with 4.35%, while individual investors own 2.02%.

The top shareholders of SBI Life Insurance include the State Bank of India, which holds the largest stake at 55.38%. In addition, foreign institutional investors (FIIs) collectively own 21.88% of the shares, while mutual funds have a significant presence with 15.0% held across 42 schemes. The highest public shareholder is ICICI Prudential Mutual Fund, specifically the ICICI Prudential NI, which holds 4.35%. Individual investors account for 2.02% of the holdings.

Read More

How big is SBI Life Insuran?

24-Jul-2025

As of 24th July, SBI Life Insurance Company Ltd has a market capitalization of 181,085.00 Cr, with recent Net Sales of 84,059.83 Cr and a Net Profit of 2,413.27 Cr. Shareholder's Funds are 14,908.56 Cr and Total Assets are valued at 3,98,298.81 Cr as of March 2024.

As of 24th July, SBI Life Insurance Company Ltd has a market capitalization of 181,085.00 Cr, categorizing it as a Large Cap company.<BR><BR>For the latest four quarters, the company reported Net Sales of 84,059.83 Cr and a Net Profit of 2,413.27 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 14,908.56 Cr and Total Assets valued at 3,98,298.81 Cr.

Read More

How has been the historical performance of SBI Life Insuran?

24-Oct-2025

SBI Life Insurance has shown consistent growth, with net sales increasing from 40,324.01 Cr in Mar'20 to 84,059.83 Cr in Mar'25, and profit after tax rising from 1,326.80 Cr to 2,413.30 Cr during the same period. Total liabilities and assets both reached 4,57,095.46 Cr in Mar'25, while cash flow from operating activities improved to 25,546.00 Cr.

Answer:<BR>The historical performance of SBI Life Insurance shows a consistent growth trajectory in net sales, with figures rising from 40,324.01 Cr in Mar'20 to 84,059.83 Cr in Mar'25. Other operating income fluctuated significantly, peaking at 51,400.69 Cr in Mar'24 before dropping to 32,828.59 Cr in Mar'25. Total operating income also saw a peak in Mar'24 at 1,31,987.79 Cr, followed by a decline to 1,16,888.42 Cr in Mar'25. The operating profit (PBDIT) has shown an upward trend, increasing from 1,641.56 Cr in Mar'19 to 2,692.60 Cr in Mar'25. Profit after tax has similarly risen, reaching 2,413.30 Cr in Mar'25, up from 1,326.80 Cr in Mar'19. The earnings per share (EPS) grew from 13.27 in Mar'19 to 24.08 in Mar'25. On the balance sheet, total liabilities increased from 1,65,580.06 Cr in Mar'20 to 4,57,095.46 Cr in Mar'25, while total assets rose from 1,65,580.06 Cr to 4,57,095.46 Cr in the same period. Cash flow from operating activities also improved, reaching 25,546.00 Cr in Mar'25, although cash flow from investing activities remained negative.<BR><BR>Breakdown:<BR>SBI Life Insurance has demonstrated significant growth in net sales, which increased from 40,324.01 Cr in Mar'20 to 84,059.83 Cr in Mar'25, indicating a strong upward trend. Other operating income varied, with a high of 51,400.69 Cr in Mar'24 before decreasing to 32,828.59 Cr in Mar'25. Total operating income peaked at 1,31,987.79 Cr in Mar'24 but fell to 1,16,888.42 Cr in Mar'25. Operating profit (PBDIT) has shown a positive trend, climbing from 1,641.56 Cr in Mar'19 to 2,692.60 Cr in Mar'25, while profit after tax rose from 1,326.80 Cr to 2,413.30 Cr over the same period. The earnings per share (EPS) also increased significantly from 13.27 to 24.08. On the balance sheet, total liabilities and total assets both grew substantially, with total liabilities rising to 4,57,095.46 Cr and total assets matching this figure in Mar'25. Cash flow from operating activities improved to 25,546.00 Cr, despite ongoing negative cash flow from investing activities.

Read More

Are SBI Life Insuran latest results good or bad?

25-Oct-2025

SBI Life Insurance's latest results show strong net sales growth of 44.65% quarter-on-quarter, but profitability declined with a 16.77% drop in net profit and a significant contraction in operating profit margins, indicating potential operational challenges. Investors should remain cautious regarding these margin pressures.

SBI Life Insurance's latest results present a mixed picture. On one hand, the company achieved impressive net sales growth of 44.65% quarter-on-quarter, reaching ₹24,848.31 crores, which is also a 22.61% increase year-on-year. This growth was largely driven by strong premium collections during the festive season.<BR><BR>However, the profitability metrics reveal significant concerns. The net profit for the quarter was ₹494.59 crores, which represents a decline of 16.77% compared to the previous quarter, although it shows a modest increase of 6.58% year-on-year. More troubling is the sharp contraction in operating profit margins, which fell to 2.07% from 3.86% in the prior quarter, indicating rising operational challenges, particularly with commission expenses and administrative costs.<BR><BR>Overall, while the top-line growth is commendable, the declining profitability and margin pressures suggest that the results are not entirely positive. Investors should be cautious and monitor whether these margin issues are temporary or indicative of deeper operational challenges.

Read More

Should I buy, sell or hold SBI Life Insuran?

25-Oct-2025

Is SBI Life Insuran technically bullish or bearish?

28-Oct-2025

As of 27 October 2025, the trend is bullish with moderate strength, supported by positive daily moving averages and monthly Bollinger Bands, although caution is advised due to mildly bearish weekly indicators; the stock has outperformed the Sensex with a year-to-date return of 36.58%.

As of 27 October 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with moderate strength. Key indicators driving this include the bullish signals from the daily moving averages and the monthly Bollinger Bands, alongside a bullish monthly MACD. However, the weekly MACD and KST are mildly bearish, suggesting some caution in the short term. The stock has shown strong performance relative to the Sensex over various time frames, particularly with a year-to-date return of 36.58% compared to 8.50% for the index.

Read More

Why is SBI Life Insuran falling/rising?

21-Dec-2025

As of 21-Dec, SBI Life Insurance Company's stock price is at 2,026.00, reflecting a recent upward trend and strong long-term performance with a year-to-date increase of 45.41%. Despite a decline in investor participation, the stock maintains strong fundamentals and positive technical indicators.

As of 21-Dec, SBI Life Insurance Company Ltd's stock price is rising, currently at 2,026.00, reflecting an increase of 11.85 (0.59%). The stock has been gaining for the last two days, with a total rise of 0.73% during this period. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its price movement.<BR><BR>Despite a slight underperformance against its sector today by -0.29%, the stock has shown strong performance over the longer term, with a year-to-date increase of 45.41% compared to the Sensex's 8.69%. The stock's performance over the past year has also been robust, generating a return of 44.40%, significantly outpacing the BSE500 index.<BR><BR>Furthermore, SBI Life Insurance has a low debt-to-equity ratio and strong long-term fundamentals, with a return on equity (ROE) of 13.4 and a price-to-book value of 11.1, which suggests an attractive valuation. High institutional holdings at 40.54% indicate confidence from larger investors, who typically have more resources to analyze company fundamentals.<BR><BR>However, it is worth noting that there has been a decline in investor participation, as evidenced by a 49.84% drop in delivery volume compared to the 5-day average. Despite this, the overall market-beating performance and strong fundamentals contribute to the stock's rising price.

Read More

Why is SBI Life Insuran falling/rising?

23-Dec-2025

As of 22-Dec, SBI Life Insurance Company's stock price is at 2,023.90, down 0.18% after a trend reversal. Despite a strong year-to-date growth of 45.26%, it has underperformed the Sensex recently and is experiencing limited volatility.

As of 22-Dec, SBI Life Insurance Company Ltd's stock price is falling, currently at 2,023.90, reflecting a decrease of 3.7 points or 0.18%. The stock has underperformed its sector by 0.75% today and has experienced a trend reversal after two consecutive days of gains. Additionally, the stock is trading 3.02% away from its 52-week high of Rs 2,085, indicating a slight pullback from recent highs.<BR><BR>In the context of broader market performance, while the stock has shown strong long-term growth with a year-to-date increase of 45.26%, it has lagged behind the Sensex in the past week, which has gained 0.42%. The stock has also traded within a narrow range of Rs 16.8, suggesting limited volatility in recent sessions. <BR><BR>Despite these short-term declines, the company maintains a low debt-to-equity ratio and strong long-term fundamentals, which could support its valuation moving forward. However, the current price movement reflects a combination of recent performance trends and market dynamics that have led to the observed decline.

Read More

Why is SBI Life Insurance Company Ltd falling/rising?

24-Dec-2025

As of 23-Dec, SBI Life Insurance Company's stock price is slightly declining at 2,022.20, down 0.03%. This decline is due to recent underperformance, falling investor participation, and a drop in delivery volume, despite strong long-term gains.

As of 23-Dec, SBI Life Insurance Company Ltd's stock price is experiencing a slight decline, currently at 2,022.20, down by 0.7 points or 0.03%. This decrease can be attributed to several factors highlighted in the recent performance data. <BR><BR>Over the past week, the stock has underperformed, showing a decline of 0.61%, while the benchmark Sensex has increased by 1.00%. Additionally, the stock has been losing for the last two consecutive days, resulting in a total drop of 0.27% during this period. The performance today also indicates that the stock underperformed its sector by 0.68%. <BR><BR>Investor participation appears to be falling, as evidenced by a significant drop in delivery volume, which decreased by 26.57% compared to the 5-day average. This decline in trading activity may reflect a lack of confidence among investors, contributing to the stock's downward movement.<BR><BR>Despite these short-term challenges, it is important to note that the stock has shown strong long-term performance, with a year-to-date increase of 45.14% and a 1-year return of 43.87%. However, the current market dynamics suggest that the stock is facing some headwinds, leading to its recent price decline.

Read More

Why is SBI Life Insurance Company Ltd falling/rising?

25-Dec-2025

As of 24-Dec, SBI Life Insurance Company Ltd is experiencing a slight decline in its stock price, down 0.08%. Despite this minor drop, the stock has strong long-term performance with a year-to-date increase of 45.12% and solid fundamentals indicating a positive outlook.

As of 24-Dec, SBI Life Insurance Company Ltd is experiencing a slight decline in its stock price, with a change of -1.7, representing a decrease of 0.08%. Despite this minor drop, the stock has shown strong performance over longer periods, with a year-to-date increase of 45.12% and a one-year return of 45.83%. <BR><BR>The stock is currently trading close to its 52-week high, just 3.12% away from Rs 2085, indicating that it has been performing well recently. However, the performance today aligns with the sector, suggesting that the decline may not be unique to SBI Life but part of broader market movements. <BR><BR>Investor participation appears to be falling, as evidenced by a significant drop in delivery volume, which decreased by 61.9% compared to the five-day average. This reduced participation could contribute to the stock's current price decline. <BR><BR>Despite the recent dip, SBI Life maintains a strong long-term outlook, characterized by a low debt-to-equity ratio and solid fundamental strength, including a return on equity of 13.4 and a price-to-book value of 11.1. High institutional holdings at 40.54% further support the stock's stability, as these investors typically have more resources to analyze company fundamentals. <BR><BR>In summary, while the stock is currently experiencing a minor decline, its overall performance remains robust, and the long-term outlook is positive, supported by strong fundamentals and historical returns.

Read More

Why is SBI Life Insurance Company Ltd falling/rising?

25-Dec-2025

As of 25-Dec, SBI Life Insurance Company Ltd's stock is slightly down by 0.08%, but it has a strong year-to-date increase of 45.12% and a one-year return of 45.83%. Despite recent declines in trading activity, the company's fundamentals remain solid, indicating a positive long-term outlook.

As of 25-Dec, SBI Life Insurance Company Ltd's stock price is experiencing a slight decline, with a change of -1.7, representing a decrease of 0.08%. Despite this minor drop, the stock has shown strong performance over longer periods, with a year-to-date increase of 45.12% and a one-year return of 45.83%, significantly outperforming the Sensex, which has only risen by 9.30% in the same timeframe.<BR><BR>The stock is currently trading close to its 52-week high, just 3.12% away from Rs 2085. However, it has been noted that there is a falling investor participation, as evidenced by a 61.9% drop in delivery volume compared to the five-day average. This decline in trading activity could be contributing to the current downward pressure on the stock price.<BR><BR>Despite the recent price drop, SBI Life Insurance Company Ltd maintains strong fundamentals, including a low debt-to-equity ratio and high institutional holdings at 40.54%. The company has also demonstrated solid profitability, with a 12.5% increase in profits over the past year. These factors suggest that while the stock may be experiencing a short-term decline, its long-term outlook remains positive, supported by strong fundamentals and market performance.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has a low Debt to Equity ratio (avg) at 0 times

 
2

Low Debt Company with Strong Long Term Fundamental Strength

 
3

Negative results in Sep 25

4

With ROE of 13.4, it has a Very Attractive valuation with a 11.1 Price to Book Value

5

High Institutional Holdings at 40.54%

6

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Insurance

stock-summary
Market cap

INR 203,048 Cr (Large Cap)

stock-summary
P/E

83.00

stock-summary
Industry P/E

24

stock-summary
Dividend Yield

0.13%

stock-summary
Debt Equity

-0.09

stock-summary
Return on Equity

13.41%

stock-summary
Price to Book

11.08

Revenue and Profits:
Net Sales:
24,848 Cr
(Quarterly Results - Sep 2025)
Net Profit:
495 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.13%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.46%
0%
11.46%
6 Months
9.9%
0%
9.9%
1 Year
46.03%
0.19%
46.22%
2 Years
45.26%
0.38%
45.64%
3 Years
65.39%
0.61%
66.0%
4 Years
76.4%
0.77%
77.17%
5 Years
131.77%
1.41%
133.18%

Latest dividend: 2.7 per share ex-dividend date: Mar-07-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Announcements stock-summary

SBI Life Insurance Company Limited - Analysts/Institutional Investor Meet/Con. Call Updates

05-Dec-2019 | Source : NSE

SBI Life Insurance Company Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

SBI Life Insurance Company Limited - Resignation

22-Nov-2019 | Source : NSE

SBI Life Insurance Company Limited has informed the Exchange regarding Resignation of Mr Somasekhar Sundaresan as Independent Director of the company w.e.f. November 21, 2019.

SBI Life Insurance Company Limited - Analysts/Institutional Investor Meet/Con. Call Updates

15-Nov-2019 | Source : NSE

SBI Life Insurance Company Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

SBI Life Insurance Company Ltd has declared 27% dividend, ex-date: 07 Mar 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
13.18%
EBIT Growth (5y)
-0.70%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
7.75
Tax Ratio
9.72%
Dividend Payout Ratio
11.21%
Pledged Shares
0
Institutional Holding
40.54%
ROCE (avg)
5.75%
ROE (avg)
13.01%
Valuation key factors
Factor
Value
P/E Ratio
83
Industry P/E
24
Price to Book Value
11.08
EV to EBIT
151.54
EV to EBITDA
151.54
EV to Capital Employed
12.14
EV to Sales
1.93
PEG Ratio
6.69
Dividend Yield
0.13%
ROCE (Latest)
8.01%
ROE (Latest)
13.41%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 41 Schemes (15.02%)

FIIs

Held by 791 FIIs (21.85%)

Promoter with highest holding

State Bank Of India (55.36%)

Highest Public shareholder

Hdfc Mutual Fund Schemes (4.06%)

Individual Investors Holdings

2.06%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 22.61% vs 1.08% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -6.58% vs 39.25% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24,848.31",
          "val2": "20,266.10",
          "chgp": "22.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "515.53",
          "val2": "605.56",
          "chgp": "-14.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "494.59",
          "val2": "529.42",
          "chgp": "-6.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.07%",
          "val2": "2.99%",
          "chgp": "-0.92%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 18.82% vs 6.69% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 3.81% vs 37.80% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "42,026.81",
          "val2": "35,371.58",
          "chgp": "18.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,179.46",
          "val2": "1,199.33",
          "chgp": "-1.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1,088.96",
          "val2": "1,048.97",
          "chgp": "3.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.81%",
          "val2": "3.39%",
          "chgp": "-0.58%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.52% vs 18.82% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 47.72% vs 14.76% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "60,199.12",
          "val2": "55,470.63",
          "chgp": "8.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,795.63",
          "val2": "1,188.31",
          "chgp": "51.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1,599.79",
          "val2": "1,082.98",
          "chgp": "47.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.91%",
          "val2": "1.24%",
          "chgp": "0.67%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 4.31% vs 21.04% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 27.43% vs 10.07% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "84,059.83",
          "val2": "80,587.10",
          "chgp": "4.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,346.47",
          "val2": "400.11",
          "chgp": "236.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2,413.30",
          "val2": "1,893.78",
          "chgp": "27.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.60%",
          "val2": "0.50%",
          "chgp": "1.10%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'25 - YoYstock-summary
Sep'25
Sep'24
Change(%)
Net Sales
24,848.31
20,266.10
22.61%
Operating Profit (PBDIT) excl Other Income
515.53
605.56
-14.87%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
494.59
529.42
-6.58%
Operating Profit Margin (Excl OI)
2.07%
2.99%
-0.92%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 22.61% vs 1.08% in Sep 2024

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Sep 2025 is -6.58% vs 39.25% in Sep 2024

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
42,026.81
35,371.58
18.82%
Operating Profit (PBDIT) excl Other Income
1,179.46
1,199.33
-1.66%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1,088.96
1,048.97
3.81%
Operating Profit Margin (Excl OI)
2.81%
3.39%
-0.58%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 18.82% vs 6.69% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 3.81% vs 37.80% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
60,199.12
55,470.63
8.52%
Operating Profit (PBDIT) excl Other Income
1,795.63
1,188.31
51.11%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1,599.79
1,082.98
47.72%
Operating Profit Margin (Excl OI)
1.91%
1.24%
0.67%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 8.52% vs 18.82% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 47.72% vs 14.76% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
84,059.83
80,587.10
4.31%
Operating Profit (PBDIT) excl Other Income
1,346.47
400.11
236.52%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
2,413.30
1,893.78
27.43%
Operating Profit Margin (Excl OI)
1.60%
0.50%
1.10%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 4.31% vs 21.04% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 27.43% vs 10.07% in Mar 2024

stock-summaryCompany CV
About SBI Life Insurance Company Ltd stock-summary
stock-summary
SBI Life Insurance Company Ltd
Large Cap
Insurance
SBI Life Insurance Company Limited (SBI Life), established in 2001, is a Joint Venture between State Bank of India (SBI) and French Financial Institution, BNP Paribas Cardif S.A. and is one of the leading life Insurance companies in India. SBI has an unrivaled strength of over 40,000 branches across the country, making it the largest banking group in India. BNP Paribas Cardif S.A. is the life and property & casualty insurance arm of BNP Paribas, one of the strongest banks in the world.
Company Coordinates stock-summary
Company Details
Natraj M V Road Andheri(East), Western Express Highway Juncti Mumbai Maharashtra : 400069
stock-summary
Tel: 91-22-61910000
stock-summary
investor@sbilife.co.in/aniket.karan
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad